Skip to main content
Clinical Trials/NCT02042755
NCT02042755
Completed
Not Applicable

Pilot Study With a Diffractive Trifocal IOL (POD AY 26P FineVision)

Beaver-Visitec International, Inc.1 site in 1 country19 target enrollmentFebruary 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bilateral Cataract
Sponsor
Beaver-Visitec International, Inc.
Enrollment
19
Locations
1
Primary Endpoint
Visual acuity
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The principal objective of the study is to determine the visual acuity at far, intermediate and near distances tested with optotypes at different distances from the eyes and tested with defocus addition lenses of patients implanted bilaterally with the POD 26P AY FineVision.

Secondary objective will be to test the glare and contrast sensitivity.

Detailed Description

This study is a pilot study. As such it will recruit a limited number of patients : 20. Patients recruited will suffer from cataract, have no comorbidity, expressed the desire for spectacle independence and have realistic expectations. Descriptive statistics will be used to determine the visual acuities at any distance. The occurence of glare and the determination of the contrast sensitivity will also be determined.

Registry
clinicaltrials.gov
Start Date
February 2014
End Date
May 2016
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • - Age-related cataract
  • Preoperative Corneal astigmatism \< 0.75 D
  • Age 21 and older
  • Visual Acuity \> 0.05
  • Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant.
  • Patient willing multifocal implantation and with realistic expectations.

Exclusion Criteria

  • Relevant other ophthalmic diseases such as pseudoexfoliation syndrome, floppy iris syndrome, corneal pathologies, retinal pathology (diabetic maculopathy, myopic maculopathy, age related macular degeneration...)
  • Previous ocular surgery or trauma.

Outcomes

Primary Outcomes

Visual acuity

Time Frame: 3 months

At far, near and intermediate distance.

Secondary Outcomes

  • Contrast sensitivity(3 months)

Study Sites (1)

Loading locations...

Similar Trials